Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for Aveanna Healthcare Holdings (AVAH) over the last 5 years, with FY2024 value amounting to $14.0 million.

  • Aveanna Healthcare Holdings' Cash from Financing Activities rose 28527.62% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 8758.43%. This contributed to the annual value of $14.0 million for FY2024, which is 2932.61% up from last year.
  • As of FY2024, Aveanna Healthcare Holdings' Cash from Financing Activities stood at $14.0 million, which was up 2932.61% from $10.8 million recorded in FY2023.
  • In the past 5 years, Aveanna Healthcare Holdings' Cash from Financing Activities ranged from a high of $586.3 million in FY2022 and a low of $10.8 million during FY2023
  • In the last 4 years, Aveanna Healthcare Holdings' Cash from Financing Activities had a median value of $62.4 million in 2022 and averaged $176.9 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 86480.06% in 2021, then crashed by 8935.4% in 2022.
  • Over the past 4 years, Aveanna Healthcare Holdings' Cash from Financing Activities (Annual) stood at $210.9 million in 2021, then tumbled by 70.41% to $62.4 million in 2022, then plummeted by 82.62% to $10.8 million in 2023, then grew by 29.33% to $14.0 million in 2024.
  • Its Cash from Financing Activities stands at $14.0 million for FY2024, versus $10.8 million for FY2023 and $62.4 million for FY2022.